Plain-English translation of NCT06796270 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new radiation therapy approach for people with nasopharyngeal cancer (a cancer that starts in the upper throat behind the nose). Instead of spreading treatment over many weeks, this study uses larger daily doses of radiation delivered over just 5 weeks. The goal is to stop cancer cells from growing back while limiting damage to healthy tissue nearby.
Standard radiation therapy for nasopharyngeal cancer can take a long time, which gives cancer cells a chance to regrow and can cause unwanted side effects. This trial is exploring whether a shorter, more intensive schedule can be more effective and easier on patients' bodies and daily lives.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would receive radiation therapy treatments 5 days a week for 5 weeks (25 total sessions). Each session delivers a slightly higher dose per day than standard radiation, allowing the overall course to be completed faster. Your doctors will monitor you throughout treatment and after to check how well the treatment worked and manage any side effects.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China
Sponsor
The Second Affiliated Hospital of Hainan Medical University
Enrollment target
~24 participants
Started
February 2026
Primary completion
December 2026
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
yuecan zeng, doctor
The Second Affiliated Hospital of Hainan Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.